FDA-Device2026-05-20Class IIPROCESSING DEFECT

Integra Codman CerebroFlo EVD Catheter recalled for elevated endotoxin levels

OTHERNationwide distribution

Codman CerebroFlo EVD Catheter recalled for endotoxin contamination

Integra LifeSciences recalled Codman CerebroFlo EVD Catheters (Product ID 37.550.501, Lot 45322) because testing found endotoxin levels that exceeded safety standards. Endotoxins are bacterial fragments that can trigger harmful immune responses in patients. The affected catheters are used to drain fluid from the brain in hospital settings.

  • If your facility received this product, do not use it and quarantine the affected lot immediately.
  • Contact your hospital's medical device or infection control team and your supplier for return instructions.
  • Check your inventory for Lot 45322 and verify product ID 37.550.501.
Hazard

Out-of-specification endotoxin result that did not meet the acceptance criteria.

Sold states
US Nationwide distribution in the states of Arizona (AZ), Arkansas (AR), California (CA), Connecticut (CT), Florida (FL), Kentucky (KY), Louisiana (LA), Michigan (MI), Minnesota (MN), Missouri (MO), North Carolina (NC), North Dakota (ND), Oklahoma (OK), Oregon (OR), Texas (TX), Washington (WA).
Affected count
40 packs (200 units)
Manufactured in
1100 Campus Rd, Princeton, NJ, United States
Products
Codman CerebroFlo EVD Catheter with Endexo Technology. Contains 5 sets. Product ID: 37.550.501. The CerebroFlo EVD Catheter is a 3.3 mm diameter (10 Fr.), 35 cm long polyurethane catheter for diverting cerebrospinal fluid (CSF) from the ventricles of the brain through a series of drainage holes near the catheter's bullet shaped tip.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2173-2026

More Integra LifeSciences Corp. (NeuroSciences) recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief